clinical trial · NCT07582874
An Expanded Access Protocol to Provide Avexitide in Patients With Post-Bariatric Hypoglycemia
Post-bariatric HypoglycemiaAvexitide
brief summary
The Expanded Access Program will provide access to avexitide for people with post-bariatric hypoglycemia (PBH) following Roux-en-Y gastric bypass (RYGB) who meet the eligibility criteria for this program. The safety of avexitide and patient treatment experience will be monitored during this program.
started
—
primary completion
—
completion
—
last updated
Jul 14, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol